129 related articles for article (PubMed ID: 1597458)
21. Uptake and degradation of 125I-labelled high density lipoproteins in rat liver cells in vivo and in vitro.
Ose L; Ose T; Norum KR; Berg T
Biochim Biophys Acta; 1979 Sep; 574(3):521-36. PubMed ID: 226159
[TBL] [Abstract][Full Text] [Related]
22. Interaction of beta-very-low-density lipoproteins with rat liver cells.
Harkes L; van Duijne A; van Berkel TJ
Eur J Biochem; 1989 Mar; 180(1):241-8. PubMed ID: 2707263
[TBL] [Abstract][Full Text] [Related]
23. Isolated rat hepatocytes acquire iron from lactoferrin by endocytosis.
McAbee DD
Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):603-9. PubMed ID: 7487902
[TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of the targeting of mannose-terminal glucocerebrosidase. Predominant uptake by liver endothelial cells.
Bijsterbosch MK; Donker W; van de Bilt H; van Weely S; van Berkel TJ; Aerts JM
Eur J Biochem; 1996 Apr; 237(2):344-9. PubMed ID: 8647071
[TBL] [Abstract][Full Text] [Related]
25. Intracellular transport of formaldehyde-treated serum albumin in liver endothelial cells after uptake via scavenger receptors.
Eskild W; Kindberg GM; Smedsrod B; Blomhoff R; Norum KR; Berg T
Biochem J; 1989 Mar; 258(2):511-20. PubMed ID: 2705996
[TBL] [Abstract][Full Text] [Related]
26. In vivo and in vitro interaction of high and low molecular weight single-chain urokinase-type plasminogen activator with rat liver cells.
Kuiper J; Rijken DC; de Munk GA; van Berkel TJ
J Biol Chem; 1992 Jan; 267(3):1589-95. PubMed ID: 1730704
[TBL] [Abstract][Full Text] [Related]
27. Processing of acetylated human low-density lipoprotein by parenchymal and non-parenchymal liver cells. Involvement of calmodulin?
Van Berkel TJ; Nagelkerke JF; Harkes L; Kruijt JK
Biochem J; 1982 Nov; 208(2):493-503. PubMed ID: 6130761
[TBL] [Abstract][Full Text] [Related]
28. Lactosylated low density lipoprotein: a potential carrier for the site-specific delivery of drugs to Kupffer cells.
Bijsterbosch MK; Ziere GJ; Van Berkel TJ
Mol Pharmacol; 1989 Sep; 36(3):484-9. PubMed ID: 2550781
[TBL] [Abstract][Full Text] [Related]
29. The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells.
Legrand D; van Berkel PH; Salmon V; van Veen HA; Slomianny MC; Nuijens JH; Spik G
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):841-6. PubMed ID: 9581564
[TBL] [Abstract][Full Text] [Related]
30. Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo.
Rensen PC; Oosten M; Bilt E; Eck M; Kuiper J; Berkel TJ
J Clin Invest; 1997 May; 99(10):2438-45. PubMed ID: 9153287
[TBL] [Abstract][Full Text] [Related]
31. Internalization of human lactoferrin by the Jurkat human lymphoblastic T-cell line.
Bi BY; Liu JL; Legrand D; Roche AC; Capron M; Spik G; Mazurier J
Eur J Cell Biol; 1996 Mar; 69(3):288-96. PubMed ID: 8900493
[TBL] [Abstract][Full Text] [Related]
32. Fate of injected glucagon taken up by rat liver in vivo. Degradation of internalized ligand in the endosomal compartment.
Authier F; Janicot M; Lederer F; Desbuquois B
Biochem J; 1990 Dec; 272(3):703-12. PubMed ID: 2268296
[TBL] [Abstract][Full Text] [Related]
33. The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.
van der Kaaden ME; Rijken DC; Kruijt JK; van Berkel TJ; Kuiper J
Thromb Haemost; 1997 Apr; 77(4):710-7. PubMed ID: 9134648
[TBL] [Abstract][Full Text] [Related]
34. Specific targeting of the antiviral drug 5-iodo 2'-deoxyuridine to the parenchymal liver cell using lactosylated poly-L-lysine.
Biessen EA; Beuting DM; Vietsch H; Bijsterbosch MK; Van Berkel TJ
J Hepatol; 1994 Nov; 21(5):806-15. PubMed ID: 7890898
[TBL] [Abstract][Full Text] [Related]
35. Interaction of human lactoferrin with the rat liver.
Debanne MT; Regoeczi E; Sweeney GD; Krestynski F
Am J Physiol; 1985 Apr; 248(4 Pt 1):G463-9. PubMed ID: 2984944
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo.
Rensen PC; van Berkel TJ
J Biol Chem; 1996 Jun; 271(25):14791-9. PubMed ID: 8662966
[TBL] [Abstract][Full Text] [Related]
37. Uptake of lactoferrin by the liver. III. Critical role of the protein moiety.
Moguilevsky N; Retegui LA; Courtoy PJ; Castracane CE; Masson PL
Lab Invest; 1984 Mar; 50(3):335-40. PubMed ID: 6321858
[TBL] [Abstract][Full Text] [Related]
38. Hepatic and extrahepatic clearance of circulating human lactoferrin: an experimental study in rat.
Peen E; Johansson A; Engquist M; Skogh T
Eur J Haematol; 1998 Sep; 61(3):151-9. PubMed ID: 9753410
[TBL] [Abstract][Full Text] [Related]
39. Hepatic and extrahepatic uptake of intravenously injected lipoprotein lipase.
Wallinder L; Peterson J; Olivecrona T; Bengtsson-Olivecrona G
Biochim Biophys Acta; 1984 Oct; 795(3):513-24. PubMed ID: 6477958
[TBL] [Abstract][Full Text] [Related]
40. Kinetics of biliary secretion of chylomicron remnant cholesterol (esters) in the rat.
van Dijk MC; Pieters M; van Berkel TJ
Eur J Biochem; 1993 Feb; 211(3):781-7. PubMed ID: 8436135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
